Isotocyanazene

Last updated

Isotocyanazene
Isotocyanazene structure.png
Identifiers
  • 1-[2-(diethylamino)ethyl]-2-[(4-prop-2-yloxyphenyl)methyl]benzimidazole-5-carbonitrile
Chemical and physical data
Formula C24H30N4O
Molar mass 390.531 g·mol−1
3D model (JSmol)
  • CC(C)Oc1ccc(cc1)Cc1nc2cc(ccc2n1CCN(CC)CC)C#N

Isotocyanazene (isotonitazene 5-cyano analogue) is a benzimidazole derivative which has been sold as a designer drug, first reported in the United Kingdom in 2025, and is presumed to have opioid effects. [1]

See also

References

  1. ↑ McHenry RD, Dunlop LC, Hudson S, Walters M, Dear JW, Lowe DJ (July 2025). "Isotocyanozene: detection of the 5-cyano analog of isotonitazene in human biological samples". Clinical Toxicology. Philadelphia, Pa.: 1–2. doi:10.1080/15563650.2025.2528990. PMID   40625206.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.